Press Release Description

Innovations in Surgical Procedures to Drive the Minimally Invasive Gastrointestinal Surgical Systems Market

A recent research report by MarkNtel Advisors has projected that the Global Minimally Invasive Gastrointestinal Surgical Systems Market will grow at around 7% CAGR during 2022-27. The rapidly increasing registration of GI diseases like colorectal cancer, GERD, hernia, & inflammatory bowel syndrome (IBS), i.e., owing to the unhealthy eating habits & changing lifestyles of people is the prime aspect predicted to propel the industry’s expansion in the coming years.

It, in turn, is demonstrating a rise in the demand for Minimally Invasive Gastrointestinal Surgical Systems and making significant contributions to the market. Moreover, the growing elderly population having higher chances of these illnesses are amongst the prominent consumers of these systems, significantly stimulating the market growth.

Furthermore, rising complications in clinical decision-making, the immense burden on radiologists, and massive investments by the governments & private companies in R&D & healthcare infrastructure, alongside possibilities of promising results in minimally invasive surgeries are the other aspects promulgating the market growth.

Surgical Robotic Systems are emerging as a Prominent Growth Opportunity for the Market

Surgical Robotics are set to make substantial contributions to the Global Minimally Invasive Gastrointestinal Surgical Systems Market growth. It owes principally to the concept being a new approach to treating GI diseases & swiftly gaining popularity worldwide. Besides, growing awareness among people about the advantages like enhanced accuracy, stability, superior range of motion, power backup, & excellent safety, among many others is also demonstrating acceptance for these systems and shaping the industry.

Moreover, across diverse regions, robotics has emerged as a gold standard approach for the treatment of GI disorders as patients have fewer infections, hernias, & less scarring. Today, surgical robots have helped overcome challenges with endoscopy systems like the limited line of sight & provide surgeons with exceptionally advanced hand skills & visions. Hence, surgical robotics holds significant potential for the leading players to participate in the market through 2027.

With Massive Investments in Advanced Surgical Systems in the US, North America to Continue Dominating the Market

On the geographical front, North America holds the largest share in the Minimally Invasive Gastrointestinal Surgical Systems Market. This dominance attributes to the increasing number of world-class medical facilities, massive investments in the healthcare sector by the governments of different countries to bring innovations in different therapeutics, and a high prevalence influx of chronic diseases, especially across countries, like the US & Canada, augmenting the demand for these systems.

Besides, other factors like changing lifestyles, improper eating habits, limited physical activity, & easy availability & frequent intake of therapeutic drugs, resulting in the growing patient pool for various GI diseases are also surging the demand for these systems across diverse healthcare facilities. The same aspect is also generating lucrative opportunities for the players to increase their production & distribution capacities to cater to the rising demands and make contributions to the overall market growth through 2027.

Competitive Landscape

The major companies in the Global Minimally Invasive Gastrointestinal Surgical Systems Market include B. Braun Melsungen AG, Conmed Corporation, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Stryker Corporation, TransEnterix, Inc., Boston Scientific Corporation, Cook Medical, Inc., Richard Wolf GmbH, Intuitive Surgical, Inc., Ambu A/S, Schölly Fiber Optic GmbH, Xenocor, Inc., Fujifilm Holdings Corporation, and Pentax Medical (Hoya Corporation).

Key Questions Answered in the Research Report

  1. What are the current & future trends in the Global Minimally Invasive Gastrointestinal Surgical Systems Market?
  2. How has the industry been evolving in terms of geography & product adoption?
  3. How has the competition been shaping across various countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers & challenges for the Global Minimally Invasive Gastrointestinal Surgical Systems Market?
  5. What are the customer orientation, purchase behavior, and expectations from the leading companies in the Global Minimally Invasive Gastrointestinal Surgical Systems Market?

Market Segmentation

  1. By Product Type (Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) (Endoscopes & Endoscopy Systems (Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopy), Videoscopes, Endoscopy Ultrasound, Therapeutic Energy Devices, Point of Sales), Surgical Robotics (Robotic Systems, Robotic Surgery Instruments & Accessories, Services))
  2. By Surgery (Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon & Rectal Surgery, Foregut Surgery, Hernia Repair, Others (Nephrectomy, Splenectomy, etc.))
  3. By End-User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers)
  4. By Region (North America, Asia-Pacific, Europe)
  5. By Country (The US, Canada, Germany, Italy, the UK, France, Spain, Japan, China, India, South Korea, Australia)